Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company has clinic operations in the Canadian cities of Mississauga, Toronto, Kitchener-Waterloo, Ottawa and Montreal. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal. Its subsidiaries include Altmed Capital Corp., Artisan Growers Ltd., KetaMD, Inc., Novo Formulations Ltd. and Tassili Life Sciences Corp.


CSE:BRAX - Post by User

Post by cautiousguyon Aug 26, 2020 7:15pm
354 Views
Post# 31458172

Pump this .... the halt continues -

Pump this .... the halt continues - https://www.bcsc.bc.ca/-/media/PWS/New-Resources/Decision-and-Orders/Cease-Trade-Orders/2020/2020-BCSECCOM-345.pdf

Which one of the Katzijamer kids are going to say this was clever move?  Hey would it be "creepy" to call the office or send emails to this bunch of wankers to voice some concern or displeasur?

Oh what do I know I am such a downer.?  I sure that this is got nothing to do with this bunch, it must be the previous bunch.  Hey good thing they kept that golden boy on -after taking him off the board- to work his magic.  That seems to have gone really well.  Right "lose-change"?


Citation: 2020 BCSECCOM 345 Cease Trade Order Champignon Brands Inc. Section 164 of the Securities Act, R.S.B.C. 1996, c. 418 ¶ 1 Champignon Brands Inc. (Champignon) is a reporting issuer in British Columbia. ¶ 2 Under National Instrument 51-102 Continuous Disclosure Obligations (NI 51-102), if a material change occurs in the affairs of the a reporting issuer, the reporting issuer must as soon as practicable, and in any event within 10 days of the date on which the change occurs, file a Form 51-102F3 Material Change Report (Form 51-102F3) with respect to the material change. ¶ 3 Form 51-102F3 requires that in respect of the closing of a restructuring transaction, the material change report must include the disclosure for each entity that resulted from the restructuring transaction required by section 14.2 of Form 51-102F5 Information Circular. ¶ 4 Champignon has filed a material change report dated April 30, 2020 that discloses the closing of an acquisition of AltMed Capital Corp. (the AltMed Material Change Report). ¶ 5 The AltMed Material Change Report does not comply with Form 51-102F3 because it does not contain the disclosure required by section 14.2 of Form 51-102F5 Information Circular for the restructuring transaction with AltMed Capital Corp. ¶ 6 Under 164(1) of the Act, the Executive Director orders that all trading in the securities of Champignon cease until: 1. it files a Form 51-102F3 for the restructuring transaction with AltMed Capital Corp., completed in accordance with the Act and rules; and 2. the Executive Director revokes this order. ¶ 7 Despite this order, a beneficial shareholder of Champignon who is not, and was not at the date of this order, an insider or control person of Champignon may sell securities of Champignon acquired before the date of this order, if both of the following apply: 1. the sale is made through a “foreign organized regulated market”, as defined in section 1.1 of the Universal Market Integrity Rules of the Investment Industry Regulatory Organization of Canada, and 2. the sale is made through an investment dealer registered in British Columbia. ¶ 8 August 26, 2020 Allan Lim, CPA, CA Manager, Corporate Disclosure Corporate Finance
<< Previous
Bullboard Posts
Next >>